Revisor Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
5,622
+909
+19% +$212K 0.34% 70
2026
Q1
$1.15M Buy
4,713
+114
+2% +$26.6K 0.32% 82
2025
Q4
$998K Buy
4,599
+9
+0.2% +$1.78K 0.27% 97
2025
Q3
$875K Sell
4,590
-726
-14% -$124K 0.3% 73
2025
Q2
$839K Sell
5,316
-61
-1% -$9.38K 0.3% 74
2025
Q1
$892K Buy
5,377
+2,798
+108% +$438K 0.4% 52
2024
Q4
$375K Sell
2,579
-2,115
-45% -$328K 0.35% 56
2024
Q3
$761K Buy
4,694
+267
+6% +$42.5K 0.48% 42
2024
Q2
$647K Sell
4,427
-2,685
-38% -$399K 0.45% 41
2024
Q1
$1.12M Buy
7,112
+4,488
+171% +$714K 0.51% 41
2023
Q4
$411K Sell
2,624
-1,580
-38% -$242K 0.47% 44
2023
Q3
$655K Buy
4,204
+1,292
+44% +$213K 0.56% 37
2023
Q2
$482K Buy
2,912
+8
+0.3% +$1.29K 0.43% 54
2023
Q1
$450K Buy
+2,904
New +$469K 0.41% 60

Other funds holding JNJ

Revisor Wealth Management's JNJ Position: Q2 2026 in Review

Revisor Wealth Management increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $212K and bringing the position to 5,622 shares worth $1.43M. The position accounts for 0.34% of the portfolio, ranked #70.

Revisor Wealth Management first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Revisor Wealth Management held 5,622 shares of Johnson & Johnson worth $1.43M as of Q2 2026.
  • Revisor Wealth Management bought 909 Johnson & Johnson shares in Q2 2026, an estimated $212K.
  • Johnson & Johnson made up 0.34% of Revisor Wealth Management's portfolio in Q2 2026, its #70 holding.
  • Revisor Wealth Management first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.